Multiple clinical studies confirm that lactate dehydrogenase (LDH) is a standard and effective biomarker used to differentiate between exudative and transudative pleural effusions, both in Light's criteria and in newer fluid-only criteria.
The retrieved papers consistently demonstrate that lactate dehydrogenase (LDH) measurements, whether alone or in combination with other markers such as cholesterol or total protein, are widely used and effective for differentiating between exudates and transudates. No papers refute the claim.